Hipolin (530853)

Turnaround

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹112.25
Market Cap₹36.85 Cr
P/E Ratio0
ROCE-24.64%
ROE-27.83%
Dividend Yield0%
Profit Growth89.47%
Debt/Equity
Sales Growth-25.4%
52-Week Range₹44.83 — ₹116.93
SectorHousehold Products
Book Value₹40.77

Strengths

Concerns

AI Analysis

Let me start with the obvious: I do not buy businesses I cannot value, and I certainly don't buy them at a premium when they are destroying capital. Hipolin is a ₹37 Cr microcap in the household products space. Sales fell 25.4% in the latest year, and the latest quarter brought only ₹4 Cr of revenue with no net profit. A P/E of 0.00 tells you that earnings are absent today. Yes, reported profit growth is +89.47%, but when you start from a loss or a zero base, percentages are meaningless. Look at the returns. ROE is -27.83%, ROCE -24.64%. Every rupee retained in the business is earning a loss. Graham would demand a margin of safety. At ₹112.25, the stock trades at 2.75 times book value of ₹40.77. That is not asset value investing; that is paying a rich price for poor economics. There is no dividend yield to compensate while waiting. Household products is a competitive, low-moat industry. Without scale or brand pricing power, a small player has little protection. Piotroski F-Score of 5/9 is mediocre, not a green light. The 52-week range shows price has risen from ₹44.83 to near ₹116.93, but price action is not evidence of intrinsic value. I cannot rely on promoter holding data because it is not disclosed here; that only adds uncertainty. A true value investor should be patient and demanding. I want to see several quarters of positive earnings, a halt in the revenue decline, and a price that offers some discount to the asset base. None of those conditions are met today. This is a possible turnaround, but the burden of proof is on the business, not on my imagination. I will pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer